Webster Brian Daniel 4

What Happened Brian Daniel Webster, President, Chief Executive Officer and a director of Kestra Medical Technologies, Ltd. (KMTS), sold 15,000 shares on March 17, 2026 in an open-market transaction. The reported weighted-average price was $20.27 per share for a total value of $304,124. The prices in the sale ranged from $20.00 to $20.7709.

Key Details

• Transaction date: March 17, 2026; Form 4 filed March 19, 2026 (within the typical 2-business-day filing window).
• Transaction type: Sale (code S); 15,000 shares disposed.
• Price: Weighted average $20.27; individual sale prices ranged $20.00–$20.7709. The filer notes they can provide a breakdown of shares sold at each price on request.
• Footnote: Sale occurred pursuant to a Rule 10b5-1 trading plan adopted September 29, 2025 (preplanned trades).
• Shares owned after the transaction: Not specified in the provided filing.

Context This was a sale under a pre-established 10b5-1 plan, which typically indicates the trades were prearranged rather than timed based on inside information. Sales are often routine and do not by themselves signal the insider’s view of the company; purchases generally carry more weight for bullish interpretation.